Related Experiment Videos
Cyclooxygenase-2 expression in colorectal adenomas.
Takanobu Sato1, Keigo Yoshinaga, Satoshi Okabe
1Department of Digestive Surgery, Tokyo Medical and Dental University Graduate School, Japan.
Diseases of the Colon and Rectum
|June 10, 2003
Summary
Cyclooxygenase-2 (COX-2) is present in most colorectal adenomas and linked to higher dysplasia grades. This suggests COX-2 is important in the adenoma-to-carcinoma sequence, a key step in colorectal cancer development.
Area of Science:
- Gastroenterology
- Oncology
- Molecular Biology
Background:
- Cyclooxygenase-2 (COX-2) is a key target for nonsteroidal anti-inflammatory drugs in preventing colorectal cancer.
- Understanding COX-2's role in early colorectal neoplasia is crucial for targeted therapies.
Purpose of the Study:
- To investigate the role of cyclooxygenase-2 (COX-2) in sporadic colorectal adenomas.
- To correlate COX-2 expression with adenoma characteristics, including dysplasia grade and tumor size.
Main Methods:
- Immunohistochemistry was used to evaluate COX-2 expression.
- The study analyzed 95 endoscopically resected colorectal adenomas.
- Multivariate logistic regression was employed to identify independent associations.
Main Results:
- Cyclooxygenase-2 (COX-2) was detected in 74% of colorectal adenomas, primarily in the cytoplasm of adenoma cells.
- COX-2 expression showed a significant association with the grade of dysplasia (P < 0.001) and tumor size (P = 0.028).
- COX-2 expression was independently associated with the grade of dysplasia (P = 0.001) in multivariate analysis.
Conclusions:
- The findings indicate that cyclooxygenase-2 (COX-2) plays a significant role in the progression of colorectal adenomas.
- These results support the involvement of COX-2 in the adenoma-to-carcinoma sequence, suggesting its potential as a therapeutic target.